Embodiments of the present invention generally relate to the field of radiotherapy. More specifically, embodiments of the present invention relate to techniques for increasing and shaping the beam output of radiotherapy systems.
A basic goal of radiotherapy treatment is the irradiation of a target volume of a patient while minimizing the amount of radiation absorbed in healthy tissue. Shaping the electron beam is an important way of minimizing the absorbed dose in healthy tissue and critical structures. Conventional collimator jaws are used for shaping a rectangular treatment field; but, as usually treatment volume is not rectangular, additional shaping is required. On a linear accelerator, lead blocks or individually made Cerrobend blocks are attached onto the treatment head under standard collimating system. Another option is the use of multileaf collimator (MLC). Multileaf collimators are becoming the main tool for beam shaping of the x-rays on the linear accelerator. It is a simple and useful system in the preparation and performance of radiotherapy treatment.
Multileaf collimators are reliable, as their manufacturers developed various mechanisms for their precision, control and reliability, together with reduction of leakage and transmission of radiation between and through the leaves. Multileaf collimators are known today as a very useful clinical system for simple field shaping, but their use is getting even more important in dynamic radiotherapy, with the leaves moving during irradiation. This enables a precise dose delivery on any part of a treated volume. Volumetric modulated arc therapy (VMAT), the therapy of the future, is based on the dynamic use of MLC.
The problem with using MLC as a field shaping device is that they are relatively slow to alter shape and therefore relatively slow to alter the field shape, e.g., the treatment volume, to the patient. It would be advantageous to provide a system with a faster field shaping response time that might reduce the overall treatment time to the patient.
Moreover, radiation treatment systems employing MLC devices typically use focused electron beams that are directed to a tungsten target to generate the x-rays. Focused electron beams create a large amount of heat on the target that must be dissipated and managed. This typically means that the incident electron beam power/dosage rate must be reduced so that the life of the target can be extended. It would be advantageous to provide a radiation treatment system that could supply a higher dose rate while still maintaining extended life of the tungsten target.
Embodiments of the present invention describe systems and methods for providing radiotherapy treatment by focusing an electron beam on a target (e.g., a tungsten plate) to produce a high-yield x-ray output with improved field shaping. A modified electron beam spatial distribution is employed to scan the target, for example, in a two-dimensional (2D) periodic path, which advantageously lowers the x-ray target temperature compared to the typical compact beam spatial distribution. As a result, the x-ray target can produce a high yield output without sacrificing the x-ray target life span. The use of a 2D periodic beam path allows a much colder target functioning regime such that more dosage can be applied in a short period of time compared to existing techniques.
In addition to reducing heat concerns on the target, the annual beam distribution on the target creates x-ray fields can be used to provide custom dose applications to a patient where the dose applications can change shape and dose distribution much faster than would otherwise be provided or possible by use of a multileaf collimator. Therefore, embodiments of the present invention provide radiotherapy in faster durations, e.g., reduced treatment times. It is appreciated that multileaf collimators (and blocks) can be used in conjunction with the x-ray fields generated via the annual beam distribution of the present invention to further shape the dose application to the patient.
According to one embodiment, a radiotherapy treatment system is disclosed, including a computer system, an electron emission device for producing and emitting an electron beam, a target, a plurality of steering coils for providing magnetic fields in perpendicular directions for steering the electron beam to the target, where the target generates x-rays responsive to interaction with the electron beam, and a beam shaping device configured to be placed between the target and a patient, the beam shaping device operable to shape a treatment volume of the x-rays. The computer system includes instructions that, when executed, cause the computer system to control the plurality of steering coils to scan the electron beam across the target in a 2D periodic path to shape the distribution of x-rays.
According to one embodiment, the electron emission device includes an electron gun and a linear accelerator coupled to receive electrons from the electron gun and operable to produce the electron beam emitted from the electron emission device.
According to one embodiment, a shape of the 2D periodic path in combination with a physical configuration and orientation of the beam shaping device defines a resultant treatment volume of x-rays exposed to the patient.
According to another embodiment, a radiotherapy treatment system is disclosed. The radiotherapy treatment system includes an electron emission device for producing and emitting an electron beam, a target, a plurality of steering coils for providing magnetic fields in perpendicular directions for steering the electron beam to the target where the target generates x-rays responsive to interaction with the electron beam, a control device coupled to the plurality of steering coils, and a beam shaping device including a multileaf collimator. The beam shaping device is configured to be placed between the target and a patient, and the beam shaping device operable to shape a treatment volume of the x-rays. The control device is operable to control the magnetic fields the plurality of steering coils to cause the electron beam to scan across the target in a 2D periodic path to produce x-rays and where further a shape of the 2D periodic path in combination with a physical configuration and orientation of the beam shaping device define a resultant treatment volume of the x-rays exposed to the patient.
According to one embodiment, the electron emission device includes an electron gun, and a linear accelerator coupled to receive electrons from the electron gun and operable to produce the electron beam, where the electron beam is of approximately 200 to 300 MeV.
According to one embodiment, the 2D periodic path includes a Lissajous type path.
According to one embodiment, the 2D periodic path includes spherical harmonic based shapes.
According to one embodiment, the spherical harmonic based shapes include a linear combination of an s-wave shape, a p-wave shape, and a d-wave shape.
According to a different embodiment, a method of generating an x-ray treatment volume using a radiotherapy treatment system is disclosed. The method includes: generating and emitting an electron beam using an electron emission device; steering the electron beam onto a target and dynamically scanning the electron beam across the target in a 2D periodic path; producing, via the target, and responsive to interaction with the electron beam being scanned thereon in accordance with the 2D periodic path, a 2D periodic distribution of x-rays; and producing a resultant treatment volume of the x-rays by shaping the 2D periodic distribution of x-rays using a beam shaping device, where a shape of the 2D periodic path in combination with a physical configuration and orientation of the beam shaping device defines the resultant treatment volume of x-rays.
According to some embodiments, the method further includes adjusting at least one of a voltage and a current over a plurality of steering coils to scan said electron beam across said target in said 2D periodic path.
According to some embodiments, the 2D periodic path comprises a convex hull.
The accompanying drawings, which are incorporated in and form a part of this specification and in which like numerals depict like elements, illustrate embodiments of the present disclosure and, together with the description, serve to explain the principles of the disclosure.
Reference will now be made in detail to several embodiments. While the subject matter will be described in conjunction with the alternative embodiments, it will be understood that they are not intended to limit the claimed subject matter to these embodiments. On the contrary, the claimed subject matter is intended to cover alternative, modifications, and equivalents, which may be included within the spirit and scope of the claimed subject matter as defined by the appended claims.
Furthermore, in the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the claimed subject matter. However, it will be recognized by one skilled in the art that embodiments may be practiced without these specific details or with equivalents thereof. In other instances, well-known methods, procedures, components, and circuits have not been described in detail as not to unnecessarily obscure aspects and features of the subject matter.
Portions of the detailed description that follow are presented and discussed in terms of a method. Although steps and sequencing thereof are disclosed in a figure herein (e.g.,
Some portions of the detailed description are presented in terms of procedures, steps, logic blocks, processing, and other symbolic representations of operations on data bits that can be performed on computer memory. These descriptions and representations are the means used by those skilled in the data processing arts to most effectively convey the substance of their work to others skilled in the art. A procedure, computer-executed step, logic block, process, etc., is here, and generally, conceived to be a self-consistent sequence of steps or instructions leading to a desired result. The steps are those requiring physical manipulations of physical quantities. Usually, though not necessarily, these quantities take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated in a computer system. It has proven convenient at times, principally for reasons of common usage, to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like.
It should be borne in mind, however, that all of these and similar terms are to be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities. Unless specifically stated otherwise as apparent from the following discussions, it is appreciated that throughout, discussions utilizing terms such as “accessing,” “displaying,” “writing,” “including,” “storing,” “rendering,” “transmitting,” “instructing,” “associating,” “identifying,” “capturing,” “controlling,” “encoding,” “decoding,” “monitoring,” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.
Embodiments of the present invention describe systems and methods for providing radiotherapy treatment using an electron emission device that produces an electron beam focused on a target (e.g., a tungsten plate) to generate a high-yield x-ray output with improved field shaping. The high-yield x-ray output and improved field shaping minimizes the radiation received by healthy tissue, increases the dosage rate/throughput of the treatment, and increases the useful lifetime of the tungsten target.
Embodiments according to the present invention use a modified electron beam spatial distribution, such as a 2D periodic beam distribution, to lower the x-ray target temperature compared to typical compact beam spatial distribution. The temperature of the target is reduced due to the 2D periodic path of the electron beam versus a compact beam profile, e.g., the heat generated from the electron beam is spread out within the target in accordance with the beam path. As a result, the electron beam output can be increased without sacrificing x-ray target life span. The use of a 2D periodic electron beam distribution allows a much colder target functioning regime such that more dosage can be applied in a short period of time compared to existing techniques. Further, the useful life of the tungsten target is increased.
According some embodiments of the present invention, the electron beam is scanned in one or more 2D periodic paths defined by one or more predetermined elementary shapes, such as Lissajous paths or spherical harmonic based shapes (e.g., s-wave, p-wave, d-wave, and so on), in order to increase the output and shape the electron beam profile. The 2D periodic path can be rapidly dynamically altered. The elementary shapes can constitute a new basis set, as compared to the Cartesian-style basis set used for multileaf collimators (MLCs). By dynamically shaping the electron field at the target, it is possible to generate beam fluence appropriate for a tumor much faster than what an MLC can do. The MLC can still be used for leakage blocking at the edge of a field instead of primary beam shaping.
In some embodiments, the electron beam configuration is changed using external magnetic fields generated by specially designed coils. In other embodiments, hollow cathodes that generate 2D periodic beams are used, and the linear accelerator is designed such that the 2D periodic distribution is preserved along the accelerator. In yet other embodiments, existing steering coils are used to perform a scanning circular motion of the beam with a frequency higher than 200 kHz to ensure that one pulse gets smeared on the target surface in one revolution.
With regard to
A 2D periodic distribution of x-rays is achieved, in one embodiment, using a pair of magnetic steering coils 120 to deflect the electron beam in accordance with a predetermined path on the x-ray target surface 125. The x-ray target surface 125 may be a high-yield target surface in the form of a tungsten plate or wedge, for example. As described in more detail below, the pair of magnetic steering coils 120 can be dynamically controlled to deflect the electron beam along a 2D periodic path on the x-ray target surface 125. The use of a 2D periodic electron beam distribution allows a much colder target functioning regime by dynamically moving the electron beam over a wider surface area versus a concentrated electron beam distribution. Because of this, the target output field 130 can be increased substantially without sacrificing the life span of the x-ray target surface 125. Dynamic electron beam scanning may be used to achieve a 2D periodic electron beam spatial distribution, and can also be used for dynamic field shaping by changing the scanning path using generalized curves.
The pair of magnetic steering coils 120 may include one or more pairs of magnetic steering coils that dynamically produce magnetic fields in perpendicular directions for steering the electron beam on the x-ray target surface 125. The magnetic field produced by the pair of magnetic steering coils 120 may be controlled by the computer system 135 (e.g., the computer system 1100 depicted in
According to some alternative embodiments, the x-ray target surface 125 is not used and the radiotherapy system 100 is used to perform electron therapy.
In the example of
In the embodiment of
With regard to
According to some embodiments, electronic signals or commands are used to control a radiotherapy device for producing a corresponding beam path based on a patient's treatment plan and one or more predetermined elementary shapes (e.g., a circle, an ellipse, a figure-eight, a clover leaf, etc.). For example, multiple shapes may be selected, and each shape may be assigned a specific weight that indicates the desired beam intensity for the corresponding shape. In one example, an electronic (e.g., digital) signal or command is sent from a power management or control unit to a pair of steering coils to vary the current or voltage over the steering coils to produce a desired shape. Moving the electron beam with respect to the patient in this way reduces target heating and increases the output of the radiotherapy system. During operation, a control signal, such as an arbitrary sine wave, may be used to trigger the radiotherapy system to generate an electron beam periodically.
According to some embodiments, the electronic signals or commands are used to control a radiotherapy device for producing arbitrary 2D shapes (e.g., a convex hull) using linear combinations of basic shape functions (e.g., a circle, an ellipse, a figure-eight, a clover leaf, etc.). Moreover, tiling two-dimensional projections of a treatment volume may be optimized for Rapid Arc type treatments that rapidly deliver precise intensity modulated radiation therapy (IMRT).
As depicted in
With regard to
With regard to
Advantageously, embodiments according to the invention can be implemented without moving parts (e.g., without moving the x-ray target). However, a 2D periodic beam distribution can be achieved by moving the x-ray target with respect to the electron beam. Moving the electron beam with respect to the target reduces target heating and increases beam output.
The computer system 1100 may also contain communications connection(s) 1122 that allow the device to communicate with other devices, e.g., in a networked environment using logical connections to one or more remote computers. Furthermore, the computer system 1100 may also include input device(s) 1124 such as, but not limited to, a voice input device, touch input device, keyboard, mouse, pen, touch input display device, etc. In addition, the computer system 1100 may also include output device(s) 1126 such as, but not limited to, a display device, speakers, printer, etc.
In the example of
It is noted that the computer system 1100 may not include all of the elements illustrated by
Embodiments of the present invention are thus described. While the present invention has been described in particular embodiments, it should be appreciated that the present invention should not be construed as limited by such embodiments, but rather construed according to the following claims.
This application is a continuation of U.S. Pat. No. 11,007,381 issued May 18, 2021, entitled “Increased Beam Output and Dynamic Field Shaping for Radiotherapy System,” by Anuj Purwar et al., which claims the benefit of U.S. Provisional Patent Application No. 62/587,331 filed Nov. 16, 2017, entitled “Increased Beam Output and Dynamic Field Shaping,” by Anuj Purwar et al., both of which are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3955089 | McIntyre | May 1976 | A |
4163901 | Azam | Aug 1979 | A |
4914681 | Klingenbeck et al. | Apr 1990 | A |
5153900 | Nomikos et al. | Oct 1992 | A |
5267294 | Kuroda | Nov 1993 | A |
5550378 | Skillicorn et al. | Aug 1996 | A |
5610967 | Moorman et al. | Mar 1997 | A |
5625663 | Swerdloff et al. | Apr 1997 | A |
5682412 | Skillicorn et al. | Oct 1997 | A |
5757885 | Yao et al. | May 1998 | A |
5949080 | Ueda | Sep 1999 | A |
6198802 | Elliott et al. | Mar 2001 | B1 |
6198957 | Green | Mar 2001 | B1 |
6222544 | Tarr et al. | Apr 2001 | B1 |
6234671 | Solomon et al. | May 2001 | B1 |
6260005 | Yang et al. | Jul 2001 | B1 |
6379380 | Satz | Apr 2002 | B1 |
6411675 | Llacer | Jun 2002 | B1 |
6445766 | Whitham | Sep 2002 | B1 |
6504899 | Pugachev et al. | Jan 2003 | B2 |
6580940 | Gutman | Jun 2003 | B2 |
6993112 | Hesse | Jan 2006 | B2 |
7190764 | Mori | Mar 2007 | B2 |
7268358 | Ma et al. | Sep 2007 | B2 |
7453983 | Schildkraut et al. | Nov 2008 | B2 |
7515681 | Ebstein | Apr 2009 | B2 |
7522706 | Lu et al. | Apr 2009 | B2 |
7560715 | Pedroni | Jul 2009 | B2 |
7590219 | Maurer, Jr. et al. | Sep 2009 | B2 |
7616735 | Maciunas et al. | Nov 2009 | B2 |
7623623 | Raanes et al. | Nov 2009 | B2 |
7778691 | Zhang et al. | Aug 2010 | B2 |
7807982 | Nishiuchi et al. | Oct 2010 | B2 |
7831289 | Riker et al. | Nov 2010 | B2 |
7835492 | Sahadevan | Nov 2010 | B1 |
7907699 | Long et al. | Mar 2011 | B2 |
8284898 | Ho et al. | Oct 2012 | B2 |
8306184 | Chang et al. | Nov 2012 | B2 |
8401148 | Lu et al. | Mar 2013 | B2 |
8406844 | Ruchala et al. | Mar 2013 | B2 |
8554302 | Gross | Oct 2013 | B2 |
8559596 | Thomson et al. | Oct 2013 | B2 |
8600003 | Zhou et al. | Dec 2013 | B2 |
8613694 | Walsh | Dec 2013 | B2 |
8636636 | Shukla et al. | Jan 2014 | B2 |
8644571 | Schulte et al. | Feb 2014 | B1 |
8716663 | Brusasco et al. | May 2014 | B2 |
8831179 | Adler | Sep 2014 | B2 |
8836332 | Shvartsman et al. | Sep 2014 | B2 |
8847179 | Fujitaka et al. | Sep 2014 | B2 |
8903471 | Heid | Dec 2014 | B2 |
8917813 | Maurer, Jr. | Dec 2014 | B2 |
8948341 | Beckman | Feb 2015 | B2 |
8958864 | Amies et al. | Feb 2015 | B2 |
8983573 | Carlone et al. | Mar 2015 | B2 |
8986186 | Zhang et al. | Mar 2015 | B2 |
8992404 | Graf et al. | Mar 2015 | B2 |
8995608 | Zhou et al. | Mar 2015 | B2 |
9018603 | Loo et al. | Apr 2015 | B2 |
9033859 | Fieres et al. | May 2015 | B2 |
9079027 | Agano et al. | Jul 2015 | B2 |
9149656 | Tanabe | Oct 2015 | B2 |
9155908 | Meltsner et al. | Oct 2015 | B2 |
9233260 | Slatkin et al. | Jan 2016 | B2 |
9258876 | Cheung et al. | Feb 2016 | B2 |
9283406 | Prieels | Mar 2016 | B2 |
9308391 | Liu et al. | Apr 2016 | B2 |
9330879 | Lewellen | May 2016 | B2 |
9333374 | Iwata | May 2016 | B2 |
9468777 | Fallone et al. | Oct 2016 | B2 |
9517358 | Velthuis et al. | Dec 2016 | B2 |
9526918 | Kruip | Dec 2016 | B2 |
9545444 | Strober et al. | Jan 2017 | B2 |
9583302 | Figueroa Saavedra et al. | Feb 2017 | B2 |
9636381 | Basile | May 2017 | B2 |
9636525 | Sahadevan | May 2017 | B1 |
9649298 | Djonov et al. | May 2017 | B2 |
9656098 | Goer | May 2017 | B2 |
9694204 | Hardemark | Jul 2017 | B2 |
9719947 | Yun | Aug 2017 | B2 |
9776017 | Flynn et al. | Oct 2017 | B2 |
9786054 | Taguchi et al. | Oct 2017 | B2 |
9786093 | Svensson | Oct 2017 | B2 |
9786465 | Li et al. | Oct 2017 | B2 |
9795806 | Matsuzaki et al. | Oct 2017 | B2 |
9801594 | Boyd et al. | Oct 2017 | B2 |
9844358 | Wiggers et al. | Dec 2017 | B2 |
9854662 | Mishin | Dec 2017 | B2 |
9874531 | Yun | Jan 2018 | B2 |
9884206 | Schulte et al. | Feb 2018 | B2 |
9931522 | Bharadwaj et al. | Apr 2018 | B2 |
9962562 | Fahrig et al. | May 2018 | B2 |
9974977 | Lachaine et al. | May 2018 | B2 |
9987502 | Gattiker et al. | Jun 2018 | B1 |
9999786 | Yoshimizu | Jun 2018 | B2 |
10007961 | Grudzinski et al. | Jun 2018 | B2 |
10022564 | Thieme et al. | Jul 2018 | B2 |
10071264 | Liger | Sep 2018 | B2 |
10080912 | Kwak et al. | Sep 2018 | B2 |
10092774 | Vanderstraten et al. | Oct 2018 | B1 |
10183179 | Smith et al. | Jan 2019 | B1 |
10188875 | Kwak et al. | Jan 2019 | B2 |
10206871 | Lin et al. | Feb 2019 | B2 |
10212800 | Agustsson et al. | Feb 2019 | B2 |
10232193 | Iseki | Mar 2019 | B2 |
10258810 | Zwart et al. | Apr 2019 | B2 |
10272264 | Ollila et al. | Apr 2019 | B2 |
10279196 | West et al. | May 2019 | B2 |
10293184 | Pishdad et al. | May 2019 | B2 |
10307614 | Schnarr | Jun 2019 | B2 |
10307615 | Ollila et al. | Jun 2019 | B2 |
10315047 | Glimelius et al. | Jun 2019 | B2 |
10349908 | Yun | Jul 2019 | B2 |
10413755 | Sahadevan | Sep 2019 | B1 |
10449389 | Ollila et al. | Oct 2019 | B2 |
10485988 | Kuusela et al. | Nov 2019 | B2 |
10525285 | Friedman | Jan 2020 | B1 |
10549117 | Vanderstraten et al. | Feb 2020 | B2 |
10603514 | Grittani et al. | Mar 2020 | B2 |
10609806 | Roecken et al. | Mar 2020 | B2 |
10636609 | Bertsche et al. | Apr 2020 | B1 |
10660588 | Boyd et al. | May 2020 | B2 |
10661100 | Shen | May 2020 | B2 |
10682528 | Ansorge et al. | Jun 2020 | B2 |
10702716 | Heese | Jul 2020 | B2 |
10758746 | Kwak et al. | Sep 2020 | B2 |
10870018 | Bartkoski et al. | Dec 2020 | B2 |
11007381 | Purwar et al. | May 2021 | B2 |
11058893 | Boyd | Jul 2021 | B2 |
20070086569 | Johnsen | Apr 2007 | A1 |
20070287878 | Fantini et al. | Dec 2007 | A1 |
20080023644 | Pedroni | Jan 2008 | A1 |
20080088059 | Tang et al. | Apr 2008 | A1 |
20090063110 | Failla et al. | Mar 2009 | A1 |
20090287467 | Sparks et al. | Nov 2009 | A1 |
20100119032 | Yan et al. | May 2010 | A1 |
20100177870 | Nord et al. | Jul 2010 | A1 |
20100178245 | Arnsdorf et al. | Jul 2010 | A1 |
20100260317 | Chang et al. | Oct 2010 | A1 |
20110006224 | Maltz et al. | Jan 2011 | A1 |
20110091015 | Yu et al. | Apr 2011 | A1 |
20110135058 | Sgouros et al. | Jun 2011 | A1 |
20120076271 | Yan et al. | Mar 2012 | A1 |
20120157746 | Meltsner et al. | Jun 2012 | A1 |
20120171745 | Itoh | Jul 2012 | A1 |
20120197058 | Shukla et al. | Aug 2012 | A1 |
20130116929 | Carlton et al. | May 2013 | A1 |
20130150922 | Butson et al. | Jun 2013 | A1 |
20130177641 | Ghoroghchian | Jul 2013 | A1 |
20130231516 | Loo et al. | Sep 2013 | A1 |
20140177807 | Lewellen et al. | Jun 2014 | A1 |
20140185776 | Li et al. | Jul 2014 | A1 |
20140206926 | van der Laarse | Jul 2014 | A1 |
20140275706 | Dean et al. | Sep 2014 | A1 |
20140369476 | Harding | Dec 2014 | A1 |
20150011817 | Feng | Jan 2015 | A1 |
20150202464 | Brand et al. | Jul 2015 | A1 |
20150260662 | Edward et al. | Sep 2015 | A1 |
20150260663 | Yun et al. | Sep 2015 | A1 |
20150306423 | Bharat et al. | Oct 2015 | A1 |
20160279444 | Schlosser | Sep 2016 | A1 |
20160310764 | Bharadwaj et al. | Oct 2016 | A1 |
20170189721 | Sumanaweera et al. | Jul 2017 | A1 |
20170203129 | Dessy | Jul 2017 | A1 |
20170281973 | Allen et al. | Oct 2017 | A1 |
20180021594 | Papp et al. | Jan 2018 | A1 |
20180043183 | Sheng et al. | Feb 2018 | A1 |
20180056090 | Jordan et al. | Mar 2018 | A1 |
20180099154 | Prieels | Apr 2018 | A1 |
20180099155 | Prieels et al. | Apr 2018 | A1 |
20180099159 | Forton et al. | Apr 2018 | A1 |
20180154183 | Sahadevan | Jun 2018 | A1 |
20180197303 | Jordan et al. | Jul 2018 | A1 |
20180207425 | Carlton et al. | Jul 2018 | A1 |
20180236268 | Zwart et al. | Aug 2018 | A1 |
20190022407 | Abel et al. | Jan 2019 | A1 |
20190022422 | Trail et al. | Jan 2019 | A1 |
20190054315 | Isola et al. | Feb 2019 | A1 |
20190070435 | Joe Anto et al. | Mar 2019 | A1 |
20190168027 | Smith et al. | Jun 2019 | A1 |
20190255361 | Mansfield | Aug 2019 | A1 |
20190299027 | Fujii et al. | Oct 2019 | A1 |
20190299029 | Inoue | Oct 2019 | A1 |
20190351259 | Lee et al. | Nov 2019 | A1 |
20200001118 | Snider, III et al. | Jan 2020 | A1 |
20200022248 | Yi et al. | Jan 2020 | A1 |
20200030633 | Van Heteren et al. | Jan 2020 | A1 |
20200035438 | Star-Lack et al. | Jan 2020 | A1 |
20200069818 | Jaskula-Ranga et al. | Mar 2020 | A1 |
20200164224 | Vanderstraten et al. | May 2020 | A1 |
20200178890 | Otto | Jun 2020 | A1 |
20200197730 | Safavi-Naeini et al. | Jun 2020 | A1 |
20200254279 | Ohishi | Aug 2020 | A1 |
20200269068 | Abel et al. | Aug 2020 | A1 |
20200276456 | Swerdloff | Sep 2020 | A1 |
20200282234 | Folkerts et al. | Sep 2020 | A1 |
Number | Date | Country |
---|---|---|
101432739 | May 2009 | CN |
102095852 | Jun 2011 | CN |
104001270 | Aug 2014 | CN |
106730407 | May 2017 | CN |
107362464 | Nov 2017 | CN |
109966662 | Jul 2019 | CN |
111481840 | Aug 2020 | CN |
111481841 | Aug 2020 | CN |
102013206252 | Oct 2014 | DE |
010207 | Jun 2008 | EA |
0269927 | Jun 1988 | EP |
0979656 | Feb 2000 | EP |
3338858 | Jun 2018 | EP |
3384961 | Oct 2018 | EP |
3421087 | Jan 2019 | EP |
3453427 | Mar 2019 | EP |
3586920 | Jan 2020 | EP |
2617283 | Jun 1997 | JP |
10-255707 | Sep 1998 | JP |
2019097969 | Jun 2019 | JP |
2006012631 | Feb 2006 | WO |
2007017177 | Feb 2007 | WO |
2007090650 | Aug 2007 | WO |
2010018476 | Feb 2010 | WO |
2013081218 | Jun 2013 | WO |
2013133936 | Sep 2013 | WO |
2014139493 | Sep 2014 | WO |
2015038832 | Mar 2015 | WO |
2015102680 | Jul 2015 | WO |
2016122957 | Aug 2016 | WO |
2017156316 | Sep 2017 | WO |
2017174643 | Oct 2017 | WO |
2018137772 | Aug 2018 | WO |
2018152302 | Aug 2018 | WO |
2019097250 | May 2019 | WO |
2019103983 | May 2019 | WO |
2019164835 | Aug 2019 | WO |
2019166702 | Sep 2019 | WO |
2019185378 | Oct 2019 | WO |
2019222436 | Nov 2019 | WO |
2020018904 | Jan 2020 | WO |
2020064832 | Apr 2020 | WO |
2020107121 | Jun 2020 | WO |
2020159360 | Aug 2020 | WO |
Entry |
---|
Aafke Christine Kraan, “Range verification methods in particle therapy: underlying physics and Monte Carlo modeling,” Frontiers in Oncology, Jul. 7, 2015, vol. 5, Article 150, 27 pages, doi: 10.3389/fonc.2015.00150. |
Wayne D. Newhauser et al., “The physics of proton therapy,” Physics in Medicine & Biology, Mar. 24, 2015, 60 R155-R209, Institute of Physics and Engineering in Medicine, IOP Publishing, doi: 10.1088/0031-9155/60/8/R155. |
S E McGowan et al., “Treatment planning optimisation in proton therapy,” Br J Radiol, 2013, 86, 20120288, The British Institute of Radiology, 12 pages, DOI: 10.1259.bjr.20120288. |
Steven Van De Water et al., “Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates,” Acta Oncologica, Jun. 26, 2019, vol. 58, No. 10, p. 1462-1469, Taylor & Francis Group, DOI: 10.1080/0284186X.2019.1627416. |
J. Groen, “FLASH optimisation in clinical IMPT treatment planning,” MSc Thesis, Jul. 1, 2020, Erasmus University Medical Center, department of radiotherapy, Delft University of Technology, 72 pages. |
Muhammad Ramish Ashraf et al., “Dosimetry for FLASH Radiotherapy: a Review of Tools and the Role of Radioluminescence and Cherenkov Emission,” Frontiers in Oncology, Aug. 21, 2020, vol. 8, Article 328, 20 pages, doi: 10.3389/fphy.2020.00328. |
Emil Schuler et al., “Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator,” International Journal of Radiation Oncology, Biology, Physics, vol. 97, No. 1, Sep. 2016, pp. 195-203. |
Elette Engels et al., “Toward personalized synchrotron microbeam radiation therapy,” Scientific Reports, 10:8833, Jun. 1, 2020, 13 pages, DOI: https://doi.org/10.1038/s41598-020-65729-z. |
P-H Mackeprang et al., “Assessing dose rate distributions in VMAT plans” (Accepted Version), Accepted Version: https://boris.unibe.ch/92814/8/dose_rate_project_revised_submit.pdf Published Version: 2016, Physics in medicine and biology, 61(8), pp. 3208-3221. Institute of Physics Publishing IOP, published Mar. 29, 2016, https://boris.unibe.ch/92814/. |
Xiaoying Liang et al., “Using Robust Optimization for Skin Flashing in Intensity Modulated Radiation Therapy for Breast Cancer Treatment: a Feasibility Study,” Practical Radiation Oncology, vol. 10, Issue 1, p. 59-69, Published by Elsevier Inc., Oct. 15, 2019. |
Alexei Trofimov et al., “Optimization of Beam Parameters and Treatment Planning for Intensity Modulated Proton Therapy,” Technology in Cancer Research & Treatment, vol. 2, No. 5, Oct. 2003, p. 437-444, Adenine Press. |
Vladimir Anferov, “Scan pattern optimization for uniform proton beam scanning,” Medical Physics, vol. 36, Issue 8, Aug. 2009, pp. 3560-3567, First published: Jul. 2, 2009. |
Ryosuke Kohno et al., “Development of Continuous Line Scanning System Prototype for Proton Beam Therapy,” International Journal of Particle Therapy, Jul. 11, 2017, vol. 3, Issue 4, p. 429-438, DOI: 10.14338/IJPT-16-00017.1. |
Wenbo Gu et al., “Integrated Beam Orientation and Scanning-Spot Optimization in Intensity Modulated Proton Therapy for Brain and Unilateral Head and Neck Tumors,” Med Phys. Author manuscript; available in PMC Apr. 1, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904040/Published in final edited form as: Med Phys. Apr. 2018; 45(4): 1338-1350. Published online Mar. 1, 2018. doi: 10.1002/mp.12788 Accepted manuscript online: Feb. 2, 2018. |
Paul Morel et al., “Spot weight adaptation for moving target in spot scanning proton therapy,” Frontiers in Oncology, May 28, 2015, vol. 5, Article 119, 7 pages, doi: 10.3389/fonc.2015.00119. |
Simeon Nill et al., “Inverse planning of intensity modulated proton therapy,” Zeitschrift fur Medizinische Physik, vol. 14, Issue 1, 2004, pp. 35-40, https://doi.org/10.1078/0939-3889-00198. |
A. Lomax, “Intensity modulation methods for proton radiotherapy,” Physics in Medicine & Biology, Jan. 1999, vol. 44, No. 1, pp. 185-205, doi: 10.1088/0031-9155/44/1/014. |
M Kramer et al., “Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization,” Physics in Medicine & Biology, 2000, vol. 45, No. 11, pp. 3299-3317, doi: 10.1088/0031-9155/45/11/313. |
Harald Paganetti, “Proton Beam Therapy,” Jan. 2017, Physics World Discovery, IOP Publishing Ltd, Bristol, UK, 34 pages, DOI: 10.1088/978-0-7503-1370-4. |
Shinichi Shimizu et al., “A Proton Beam Therapy System Dedicated to Spot-Scanning Increases Accuracy with Moving Tumors by Real-Time Imaging and Gating and Reduces Equipment Size,” PLoS ONE, Apr. 18, 2014, vol. 9, Issue 4, e94971, https://doi.org/10.1371/journal.pone.0094971. |
Heng Li et al., “Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence,” International Journal of Radiation Oncology, Biology, Physics, vol. 93, Issue 3, Nov. 1, 2015, pp. 547-556, available online Jun. 18, 2015, https://doi.org/10.1016/j.ijrobp.2015.06.019. |
Ion Beam Applications SA, “Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation,” Imaging Technology News, May 2, 2019, Wainscot Media, https://www.itnonline.com/content/netherlands-proton-therapy-center-delivers-first-clinical-flash-irradiation. |
R. M. De Kruijff, “FLASH radiotherapy: ultra-high dose rates to spare healthy tissue,” International Journal of Radiation Biology, 2020, vol. 96, No. 4, pp. 419-423, published online: Dec. 19, 2019, https://doi.org/10.1080/09553002.2020.1704912. |
Mevion Medical Systems, “Focus on the Future: Flash Therapy,” Press Releases, Sep. 16, 2019, https://www.mevion.com/newsroom/press-releases/focus-future-flash-therapy. |
Joseph D. Wilson et al., “Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?”, Frontiers in Oncology, Jan. 17, 2020, vol. 9, Article 1563, 12 pages, doi: 10.3389/fonc.2019.01563. |
David P. Gierga, “Is Flash Radiotherapy coming?”, International Organization for Medical Physics, 2020, https://www.iomp.org/iomp-news2-flash-radiotherapy/. |
Abdullah Muhammad Zakaria et al., “Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment,” Radiation Research, Dec. 1, 2020, vol. 194, Issue 6, pp. 587-593, Radiation Research Society, Published: Aug. 27, 2020, doi: https://doi.org/10.1667/RADE-19-00015.1. |
Yusuke Demizu et al., “Carbon Ion Therapy for Early-Stage Non-Small-Cell Lung Cancer,” BioMed Research International, vol. 2014, Article ID 727962, 9 pages, Hindawi Publishing Corporation, published: Sep. 11, 2014, https://doi.org/10.1155/2014/727962. |
Ivana Dokic et al., “Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams,” Oncotarget, Aug. 30, 2016, vol. 7, No. 35, pp. 56676-56689, published online: Aug. 1, 2016, doi: 10.18632/oncotarget.10996. |
Aetna Inc., “Proton Beam, Neutron Beam, and Carbon Ion Radiotherapy,” 2020, No. 0270, http://www.aetna.com/cpb/medical/data/200_299/0270.html. |
Nicholas W. Colangelo et al., “The Importance and Clinical Implications of FLASH Ultra-High Dose-Rate Studies for Proton and Heavy Ion Radiotherapy,” Radiat Res. Author manuscript; available in PMC Jan. 1, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949397/Published in final edited form as: Radiat Res. Jan. 2020; 193(1): 1-4. Published online Oct 28, 2019. doi: 10.1667/RR15537.1. |
Vincent Favaudon et al., “Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice,” Science Translational Medicine, Jul. 16, 2014, vol. 6, Issue 245, 245ra93, American Association for the Advancement of Science, DOI: 10.1126/scitranslmed.3008973. |
“FlashRad: Ultra-high dose-rate FLASH radiotherapy to minimize the complications of radiotherapy,” 2014, https://siric.curie.fr/sites/default/files/atoms/files/flashrad.pdf. |
Tami Freeman, “FLASH radiotherapy: from preclinical promise to the first human treatment,” Physics World, Aug. 6, 2019, IOP Publishing Ltd, https://physicsworld.com/a/flash-radiotherapy-from-preclinical-promise-to-the-first-human-treatment/. |
Intraop Medical, Inc., “IntraOp and Lausanne University Hospital Announce Collaboration in FLASH radiotherapy,” Jun. 18, 2020, https://intraop.com/news-events/lausanne-university-flash-radiotherapy-collaboration/. |
M.-C. Vozenin et al., “Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken,” Clin Oncol (R Coll Radiol). Author manuscript; available in PMC Nov. 12, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850216/Published in final edited form as: Clin Oncol (R Coll Radiol). Jul. 2019; 31(7): 407-415. Published online Apr. 19, 2019. doi: 10.1016/j.clon.2019.04.001. |
Efstathios Kamperis et al., “A Flash back to radiotherapy's past and then fast forward to the future,” J Cancer Prev Curr Res. 2019;10(6):142-144. published Nov. 13, 2019, DOI: 10.15406/jcpcr.2019.10.00407. |
P. Symonds et al., “FLASH Radiotherapy: the Next Technological Advance in Radiation Therapy?”, Clinical Oncology, vol. 31, Issue 7, p. 405-406, Jul. 1, 2019, The Royal College of Radiologists, Published by Elsevier Ltd., DOI: https://doi.org/10.1016/j.clon.2019.05.011. |
Swati Girdhani et al., “Abstract LB-280: FLASH: a novel paradigm changing tumor irradiation platform that enhances therapeutic ratio by reducing normal tissue toxicity and activating immune pathways,” Proceedings: AACR Annual Meeting 2019; Mar. 29-Apr. 3, 2019; Atlanta, GA, published Jul. 2019, vol. 79, Issue 13 Supplement, pp. LB-280, American Association for Cancer Research, DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-280. |
Bazalova-Carter et al., “On the capabilities of conventional x-ray tubes to deliver ultra-high (FLASH) dose rates,” Med. Phys. Dec. 2019; 46 (12):5690-5695, published Oct. 23, 2019, American Association of Physicists in Medicine, doi: 10.1002/mp.13858. Epub Oct. 23, 2019. PMID: 31600830. |
Manuela Buonanno et al., “Biological effects in normal cells exposed to FLASH dose rate protons,” Radiother Oncol. Author manuscript; available in PMC Oct. 1, 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728238/Published in final edited form as: Radiother Oncol. Oct. 2019; 139: 51-55. Published online Mar. 5, 2019. doi: 10.1016/j.radonc.2019.02.009. |
N. Rama et al., “Improved Tumor Control Through T-cell Infiltration Modulated by Ultra-High Dose Rate Proton FLASH Using a Clinical Pencil Beam Scanning Proton System,” International Journal of Radiation Oncology, Biology, Physics, vol. 105, Issue 1, Supplement , S164-S165, Sep. 1, 2019, Mini Oral Sessions, DOI: https://doi.org/10.1016/j.ijrobp.2019.06.187. |
Inserm Press Office, “Radiotherapy ‘flashes’ to reduce side effects,” Press Release, Jul. 16, 2014, https://presse.inserm.fr/en/radiotherapy-flashes-to-reduce-side-effects/13394/. |
Eric S. Diffenderfer et al., “Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System,” International Journal of Radiation Oncology, Biology, Physics, vol. 106, Issue 2, Feb. 1, 2020, pp. 440-448, Available online Jan. 9, 2020, Published by Elsevier Inc., DOI: https://doi.org/10.1016/j.ijrobp.2019.10.049. |
Valerie Devillaine, “Radiotherapy and Radiation Biology,” Institut Curie, Apr. 21, 2017, https://institut-curie.org/page/radiotherapy-and-radiation-biology. |
Imaging Technology News, “ProNova and medPhoton to Offer Next Generation Beam Delivery, Advanced Imaging for Proton Therapy,” Oct. 6, 2014, Wainscot Media, Link: https://www.itnonline.com/content/pronova-and-medphoton-offer-next-generation-beam-delivery-advanced-imaging-proton-therapy. |
Oncolink Team, “Radiation Therapy: Which type is right for me?”, OncoLink Penn Medicine, last reviewed Mar. 3, 2020, Trustees of the University of Pennsylvania, https://www.oncolink.org/cancer-treatment/radiation/introduction-to-radiation-therapy/radiation-therapy-which-type-is-right-for.me. |
Marco Durante et al., “Faster and safer? FLASH ultra-high dose rate in radiotherapy,” Br J Radiol 2018; 91(1082): 20170628, British Institute of Radiology, Published Online: Dec. 15, 2017, https://doi.org/10.1259/bjr.20170628. |
John R. Fischer, “PMB launches FLASH radiotherapy system for use in clinical trials,” HealthCare Business News, Jun. 29, 2020, DOTmed.com, Inc., https://www.dotmed.com/news/story/51662. |
Marie-Catherine Vozenin et al., “The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients,” Clinical Cancer Research, Author Manuscript Published OnlineFirst Jun. 6, 2018, https://clincancerres.aacrjournals.org/content/clincanres/early/2018/06/06/1078-0432.CCR-17-3375.full.pdf. |
M. McManus et al., “The challenge of ionisation chamber dosimetry in ultra-short pulsed high dose-rate Very High Energy Electron beams,” Sci Rep 10, 9089 (2020), published Jun. 3, 2020, https://doi.org/10.1038/S41598-020-65819-y. |
Ibrahim Oraiqat et al., “An Ionizing Radiation Acoustic Imaging (iRAI) Technique for Real-Time Dosimetric Measurements for FLASH Radiotherapy,” Medical Physics, vol. 47, Issue10, Oct. 2020, pp. 5090-5101, First published: Jun. 27, 2020, https://doi.org/10.1002/mp.14358. |
K. Petersson et al., “Dosimetry of ultra high dose rate irradiation for studies on the biological effect induced in normal brain and GBM,” ICTR-PHE 2016, p. S84, Feb. 2016, https://publisher-connector.core.ac.uk/resourcesync/data/elsevier/pdf/14c/aHR0cDovL2FwaS5lbHNIdmllci5jb20vY29udGVudC9hcnRpY2xIL3BpaS9zMDE2NzgxNDAxNjMwMTcyNA==pdf. |
Susanne Auer et al., “Survival of tumor cells after proton irradiation with ultra-high dose rates,” Radiation Oncology 2011, 6:139, Published Oct. 18, 2011, DOI: https://doi.org/10.1186/1748-717X-6-139. |
Cynthia E. Keen, “Clinical linear accelerator delivers FLASH radiotherapy,” Physics World, Apr. 23, 2019, IOP Publishing Ltd, https://physicsworld.com/a/clinical-linear-accelerator-delivers-flash-radiotherapy/. |
Fan et al., “Emission guided radiation therapy for lung and prostate cancers: a feasibility study on a digital patient,” Med Phys. Nov. 2012; 39(11): 7140-7152. Published online Nov. 5, 2012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505203/doi: 10.1118/1.4761951. |
Favaudon et al., “Ultrahigh dose-rate, “flash” irradiation minimizes the side-effects of radiotherapy,” Cancer / Radiotherapy, vol. 19, Issues 6-7 , Oct. 2015 , pp. 526-531, Available online Aug. 12, 2015, https://doi.org/10.1016/j.canrad.2015.04.006. |
O. Zlobinskaya et al., “The Effects of Ultra-High Dose Rate Proton Irradiation on Growth Delay in the Treatment of Human Tumor Xenografts in Nude Mice,” Radiation Research, 181(2):177-183. Published Feb. 13, 2014, DOI: http://dx.doi.org/10.1667/RR13464.1. |
Bjorn Zackrisson, “Biological Effects of High Energy Radiation and Ultra High Dose Rates,” UMEA University Medical Dissertations, New series No. 315—ISSN 0346-6612, From the Department of Oncology, University of Umea, Umea, Sweden, ISBN 91-7174-614-5, Printed in Sweden by the Printing Office of Umea University, Umea, 1991. |
P. Montay-Gruel et al., “Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s,” Radiotherapy and Oncology, vol. 124, Issue 3, Sep. 2017, pp. 365-369, Available online May 22, 2017, doi: 10.1016/j.radonc.2017.05.003. |
Bw Loo et al., “Delivery of Ultra-Rapid Flash Radiation Therapy and Demonstration of Normal Tissue Sparing After Abdominal Irradiation of Mice,” International Journal of Radiation Oncology, Biology, Physics, vol. 98, Issue 2, p. E16, Supplements Meeting Abstract: P003, Published: Jun. 1, 2017, DOI: https://doi.org/10.1016/j.ijrobp.2017.02.101. |
Bhanu Prasad Venkatesulu et al., “Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome,” Sci Rep 9, 17180 (2019), Published Nov. 20, 2019, DOI: https://doi.org/10.1038/s41598-019-53562-y. |
P. Montay-Gruel et al., “Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species,” PNAS May 28, 2019, vol. 116, No. 22, pp. 10943-10951; first published May 16, 2019, https://doi.org/10.1073/pnas.1901777116. |
Peter G. Maxim et al., “FLASH radiotherapy: Newsflash or flash in the pan?”, Medical Physics, 46 (10), Oct. 2019, pp. 4287-4290, American Association of Physicists in Medicine, First published: Jun. 27, 2019, https://doi.org/10.1002/mp.13685. |
Andrei Pugachev et al., “Pseudo beam's-eye-view as applied to beam orientation selection in intensity-modulated radiation therapy,” Int. J. Radiation Oncology Biol. Phys., vol. 51, Issue 5, P1361-1370, Dec. 1, 2001, DOI: https://doi.org/10.1016/S0360-3016(01)01736-9. |
Xiaodong Zhang et al., “Intensity-Modulated Proton Therapy Reduces the Dose to Normal Tissue Compared With Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small-Cell Lung Cancer: a Virtual Clinical Study,” Int. J. Radiation Oncology Biol. Phys., vol. 77, No. 2, pp. 357-366, 2010, Available online Aug. 5, 2009, DOI: https://doi.org/10.1016/j.ijrobp.2009.04.028. |
A. J. Lomax et al, “Intensity modulated proton therapy: a clinical example,” Medical Physics, vol. 28, Issue 3, Mar. 2001, pp. 317-324, First published: Mar. 9, 2001, https://doi.org/10.1118/1.1350587. |
Lamberto Widesott et al., “Intensity-Modulated Proton Therapy Versus Helical Tomotherapy in Nasopharynx Cancer: Planning Comparison and NTCP Evaluation,” Int. J. Radiation Oncology Biol. Phys., vol. 72, No. 2, pp. 589-596, Oct. 1, 2008, Available online Sep. 13, 2008, DOI: https://doi.org/10.1016/j.ijrobp.2008.05.065. |
Andrei Pugachev et al., “Role of beam orientation optimization in intensity-modulated radiation therapy,” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 2, pp. 551-560, Jun. 1, 2001, Available online May 10, 2001, DOI: https://doi.org/10.1016/S0360-3016(01)01502-4. |
Damien C. Weber et al., “Radiation therapy planning with photons and protons for eady and advanced breast cancer: an overview,” Radiat Oncol. 2006; 1: 22. Published online Jul. 20, 2006, doi: 10.1186/1748-717X-1-22. |
RaySearch Laboratories, “Leading the way in cancer treatment, Annual Repod 2013,” RaySearch Laboratories (publ), Stockholm, Sweden, 94 pages, Apr. 2014, https://www.raysearchlabs.com/siteassets/about-overview/media-center/wp-re-ev-n-pdfs/brochures/raysearch-ar-2013-eng-pdf. |
Fredrik Carlsson, “Utilizing Problem Structure in Optimization of Radiation Therapy,” KTH Engineering Sciences, Doctoral Thesis, Stockholm, Sweden, Apr. 2008, Optimization and Systems Theory, Department of Mathematics, Royal Institute of Technology, Stockholm, Sweden, ISSN 1401-2294, https://www.raysearchlabs.com/globalassets/about-overview/media-center/wp-re-ev-n-pdfs/publications/thesis-fredrik_light.pdf. |
Chang-Ming Charlie MA, “Physics and Dosimetric Principles of SRS and SBRT,” Mathews J Cancer Sci. 4(2): 22, 2019, published: Dec. 11, 2019, ISSN: 2474-6797, DOI: https://doi.org/10.30654/MJCS.10022. |
Alterego-admin, “Conventional Radiation Therapy May Not Protect Healthy Brain Cells,” International Neuropsychiatric Association—INA, Oct. 10, 2019, https://inawebsite.org/conventional-radiation-therapy-may-not-protect-healthy-brain-cells/. |
Number | Date | Country | |
---|---|---|---|
20210220674 A1 | Jul 2021 | US |
Number | Date | Country | |
---|---|---|---|
62587331 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16193794 | Nov 2018 | US |
Child | 17227156 | US |